May 24 (Reuters) - Indian generic drugmaker Emcure Pharmaceuticals (EMCU.NS), opens new tab and U.S. vaccine developer HDT Bio have settled allegations that Emcure stole HDT trade secrets during their ...
Shares of Emcure Pharma shall be in focus during the trading session on Friday as Bain Capital-affiliated entity BC Investments IV is likely to offload 2.4 per cent stake in the company for Rs 551 ...
Earnings call Emcure Pharmaceuticals reported Q3 FY26 revenue of INR 2,363 crore, up 20.4% YoY, with PAT rising 48% to INR 231 crore (65% adjusted). EBITDA margin expanded 110 bps to 19.5%. Management ...
Mar 25, 2026, 1:15 AM IST Emcure Pharma. - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Mar 24, 2026, 7:44 PM IST Emcure Pharma. - Update On Re-Appointment Of Independent Directors Mar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results